After looking for nearly six months, the Federal Reserve says it couldn’t find out who had shared confidential policy information. Critics in Congress aren’t satisfied with the account.
As congressional critics push for reform of Wall Street’s lead regulator, Fed Chairwoman Janet Yellen says more of the decisions on bank oversight have shifted to Washington, D.C.
Ben Bernanke ordered an internal review of a previously undisclosed leak that found its way into a newsletter for big investors, revealing confidential bond-buying details.
Examiners are reportedly blocked from doing their job as “London Whale” trades blow up.
Bank President William Dudley says supervision is stronger than ever, but Democratic senators are unconvinced: "You need to fix it, Mr. Dudley, or we need to get someone who will."
The Federal Reserve Board wants to look at whether the views of examiners are being heard by higher-ups.
A confidential report and a fired examiner’s hidden recorder penetrate the cloistered world of Wall Street’s top regulator—and its history of deference to banks.
Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."
A new study finds that New York’s three-quarter houses are dangerous and unsanitary and residents say they are compelled to use drug clinics that pay kickbacks to landlords.
Lawyer Carmen Segarra said she was pressured to change her finding that the way Goldman Sachs managed conflicts of interest was flawed.
Homeless and struggling with sobriety, Lillian Imbert faced a choice: Go to useless counseling sessions at New York Service Network or be evicted from her “sober” home. Her story shows how drug treatment clinics and landlords traffic in indigent alcoholics and addicts, all at taxpayer expense.